Morgan Stanley’s ImageneBio, Inc. Common Stock IMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.7K | Buy |
2,285
+1,237
| +118% | +$19.9K | ﹤0.01% | 6460 |
|
|
2025
Q1 | $16.1K | Sell |
1,048
-236
| -18% | -$3.62K | ﹤0.01% | 6643 |
|
|
2024
Q4 | $25.3K | Hold |
1,284
| – | – | ﹤0.01% | 6501 |
|
|
2024
Q3 | $26.6K | Sell |
1,284
-2,122
| -62% | -$44K | ﹤0.01% | 6408 |
|
|
2024
Q2 | $67.4K | Sell |
3,406
-714
| -17% | -$14.1K | ﹤0.01% | 6090 |
|
|
2024
Q1 | $70.2K | Sell |
4,120
-7,310
| -64% | -$125K | ﹤0.01% | 6113 |
|
|
2023
Q4 | $270K | Buy |
11,430
+10,120
| +773% | +$239K | ﹤0.01% | 5830 |
|
|
2023
Q3 | $68K | Buy |
1,310
+61
| +5% | +$3.17K | ﹤0.01% | 6038 |
|
|
2023
Q2 | $98.3K | Buy |
1,249
+125
| +11% | +$9.84K | ﹤0.01% | 5961 |
|
|
2023
Q1 | $46.5K | Buy |
1,124
+818
| +267% | +$33.9K | ﹤0.01% | 6314 |
|
|
2022
Q4 | $9.76K | Sell |
306
-3,987
| -93% | -$127K | ﹤0.01% | 6948 |
|
|
2022
Q3 | $183K | Sell |
4,293
-1,966
| -31% | -$83.8K | ﹤0.01% | 5762 |
|
|
2022
Q2 | $332K | Buy |
6,259
+5,183
| +482% | +$275K | ﹤0.01% | 5631 |
|
|
2022
Q1 | $78K | Buy |
1,076
+64
| +6% | +$4.64K | ﹤0.01% | 6467 |
|
|
2021
Q4 | $153K | Buy |
1,012
+743
| +276% | +$112K | ﹤0.01% | 6204 |
|
|
2021
Q3 | $41K | Buy |
269
+239
| +797% | +$36.4K | ﹤0.01% | 6801 |
|
|
2021
Q2 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 7379 |
|